Celldex Therapeutics Inc
SWB:TCE2
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Celldex Therapeutics Inc
SWB:TCE2
|
US |
|
S
|
Sanlam Ltd
JSE:SLM
|
ZA |
|
M
|
Macquarie Group Ltd
F:4M4
|
AU |
|
Suzuki Motor Corp
TSE:7269
|
JP |
|
Proto Labs Inc
NYSE:PRLB
|
US |
|
Turkcell Iletisim Hizmetleri AS
F:TUL1
|
TR |
|
C
|
CBRE Group Inc
XBER:RF6
|
US |
|
C
|
CME Group Inc
LSE:0HR2
|
US |
|
S
|
Sino Land Co Ltd
OTC:SNLAF
|
HK |
|
I
|
Interpublic Group of Companies Inc
SWB:IPG
|
US |
|
F
|
Ferrari NV
XETRA:2FE
|
IT |
|
R
|
Relx PLC
OTC:RLXXF
|
UK |
|
Nexgen Energy Ltd
F:6NEA
|
CA |
|
Alpha Services and Holdings SA
OTC:ALBKY
|
GR |
|
A
|
Albemarle Corp
F:AMC
|
US |
|
R
|
Relx PLC
XHAM:RDEB
|
UK |
|
I
|
Intel Corp
DUS:INL
|
US |
|
C
|
Cbrain A/S
XBER:C6F
|
DK |
|
R
|
Remgro Ltd
XMUN:RE7
|
ZA |
|
K
|
KeyCorp
XBER:KEY
|
US |
|
M
|
Mckesson Corp
LSE:0JZU
|
US |
|
W
|
Wendys Co
XMUN:TQK
|
US |
|
C
|
China Resources Beer Holdings Co Ltd
XMUN:CHK
|
HK |
Bankruptcy Probability
Celldex Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Celldex Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Celldex Therapeutics Inc
NASDAQ:CLDX
|
2.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
444.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
195.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
156.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
126.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
65.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
49.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Celldex Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Celldex Therapeutics Inc has no debt.
You can find a full breakdown on its Balance Sheet.
